Forest Pharma is announcing the Linaclotide (IRWD main product with a PDUFA)
Forest Pharma or Forest Laboratories (FRX) is already announcing to their shareholders what a blockbuster drug.........of Ironwood (IRWD) will be !!!!
I quote "We expect to hear from the U.S. Food and Drug Administration (FDA) in the coming weeks regarding the approval status of aclidinium for the long-term maintenance treatment of COPD and later this summer we expect to hear on the approval status of linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). Assuming approval for both products we will have two new product launches during fiscal 2013."